Class information for:
Level 2: LEVOSIMENDAN//CALCIUM SENSITIZERS//CALCIUM SENSITIZER

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1446 7310 30.6 56%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
24 112627 HYPERTENSION//JOURNAL OF HYPERTENSION//HEART FAILURE

Classes in level below (level 1)


ID, lev. below Publications Label for level below
3826 1826 ENOXIMONE//AMRINONE//MILRINONE
4154 1761 DIGOXIN//DIGOXIN TOXICITY//SERUM DIGOXIN CONCENTRATION
6427 1419 FLOSEQUINAN//BTS 53 554//FIRST DOSE HYPOTENSION
10578 985 LEVOSIMENDAN//CALCIUM SENSITIZERS//CALCIUM SENSITIZER
17650 525 XAMOTEROL//EPANOLOL//DENOPAMINE
24239 266 IBOPAMINE//EPININE//NOLOMIROLE
25412 234 TSC 22//VESNARINONE//POSITIVE INOTROPIC ACTIVITY
28163 173 CHRONIC VOLUME LOAD//CARBON 13 LABELED SUBSTRATES//CLIN PHARMACOL INTERNAL PROPEDEUT
31563 121 BDF 9148//DPI 201 106//NA CHANNEL MODULATORS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LEVOSIMENDAN Author keyword 499 76% 5% 347
2 CALCIUM SENSITIZERS Author keyword 89 92% 0% 35
3 CALCIUM SENSITIZER Author keyword 78 81% 1% 47
4 TSC 22 Author keyword 77 96% 0% 24
5 VESNARINONE Author keyword 71 77% 1% 48
6 ENOXIMONE Author keyword 70 67% 1% 64
7 CA2 SENSITIZER Author keyword 55 87% 0% 27
8 MILRINONE Author keyword 52 37% 2% 112
9 DIGOXIN Author keyword 50 20% 3% 219
10 MCI 154 Author keyword 49 94% 0% 17

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 LEVOSIMENDAN 499 76% 5% 347 Search LEVOSIMENDAN Search LEVOSIMENDAN
2 CALCIUM SENSITIZERS 89 92% 0% 35 Search CALCIUM+SENSITIZERS Search CALCIUM+SENSITIZERS
3 CALCIUM SENSITIZER 78 81% 1% 47 Search CALCIUM+SENSITIZER Search CALCIUM+SENSITIZER
4 TSC 22 77 96% 0% 24 Search TSC+22 Search TSC+22
5 VESNARINONE 71 77% 1% 48 Search VESNARINONE Search VESNARINONE
6 ENOXIMONE 70 67% 1% 64 Search ENOXIMONE Search ENOXIMONE
7 CA2 SENSITIZER 55 87% 0% 27 Search CA2+SENSITIZER Search CA2+SENSITIZER
8 MILRINONE 52 37% 2% 112 Search MILRINONE Search MILRINONE
9 DIGOXIN 50 20% 3% 219 Search DIGOXIN Search DIGOXIN
10 MCI 154 49 94% 0% 17 Search MCI+154 Search MCI+154

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CALCIUM SENSITIZER 342 86% 2% 177
2 CARDIOTONIC AGENT 265 84% 2% 147
3 INTRAVENOUS LEVOSIMENDAN 195 87% 1% 97
4 CA2 SENSITIZER 164 93% 1% 63
5 MILRINONE 159 48% 3% 242
6 CALCIUM SENSITIZER LEVOSIMENDAN 150 96% 1% 47
7 AMRINONE 146 64% 2% 142
8 MAINTENANCE DIGOXIN 98 100% 0% 29
9 INOTROPIC AGENTS 97 68% 1% 86
10 EMD 53998 94 94% 0% 33

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies 2012 48 90 84%
Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis 2015 3 60 68%
Levosimendan: Molecular mechanisms and clinical implications Consensus of experts on the mechanisms of action of levosimendan 2012 24 92 87%
Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion 2015 1 63 81%
A Bayesian network meta-analysis on the effect of inodilatory agents on mortality 2015 1 45 80%
CARDIOMYOPATHY OF OVERLOAD - A MAJOR DETERMINANT OF PROGNOSIS IN CONGESTIVE HEART-FAILURE 1990 442 86 21%
Levosimendan, a new inotropic and vasodilator agent 2006 72 118 80%
TO WHAT EXTENT DO CONGESTIVE HEART-FAILURE PATIENTS IN SINUS RHYTHM BENEFIT FROM DIGOXIN THERAPY - A SYSTEMATIC OVERVIEW AND METAANALYSIS 1990 105 28 75%
Evidence-based use of levosimendan in different clinical settings 2006 64 64 86%
Inotropes 2014 6 63 54%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CARDIOVASC PROJECTS 8 100% 0.1% 5
2 CARDIOTHORAC ANAESTHESIA INTENS CARE UNIT 4 75% 0.0% 3
3 NAT OURCES FUNCT MOL CHANGBAI MT 3 24% 0.1% 10
4 PHYSIOL EXPT SURG 3 60% 0.0% 3
5 STRAZHESKO CARDIOL 3 60% 0.0% 3
6 CARDIOVASC PHARMACOL GRP 3 35% 0.1% 6
7 KLINIKUM WEIDEN 2 67% 0.0% 2
8 OFF HAL 18 D2 2 67% 0.0% 2
9 TOXICOL INTENS CARE UNIT 2 67% 0.0% 2
10 DRUG DISCOVERY PHARMACOL 2 40% 0.1% 4

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000017404 HEREDITARY ANGIOEDEMA//C1 INHIBITOR//ANGIOEDEMA
2 0.0000017398 HEART FAILURE//NATRIURETIC PEPTIDES//B TYPE NATRIURETIC PEPTIDE
3 0.0000014790 NITRATE TOLERANCE//NITROGLYCERIN//ORGANIC NITRATES
4 0.0000013754 ASCLEPIADACEAE//MARINOBUFAGENIN//OUABAIN
5 0.0000013752 CARVEDILOL//NEBIVOLOL//BETA BLOCKERS
6 0.0000008952 AMIODARONE//DESETHYLAMIODARONE//PROPAFENONE
7 0.0000008323 UNITE CARDIOL ALFORT//JOURNAL OF VETERINARY CARDIOLOGY//UNITE PHARM TOXICOL
8 0.0000008316 TIANEPTINE//PYRIDAZINONE//PYRIDAZINONES
9 0.0000008045 CHLOROETHYLCLONIDINE//ALPHA1 ADRENOCEPTOR SUBTYPE//BETA3 ADRENOCEPTORS
10 0.0000007666 TORASEMIDE//HYPERKALEMIA//FUROSEMIDE